NEW YORK (GenomeWeb news) – Luminex reported after the close of the market on Wednesday that its third-quarter 2009 revenues rose nearly one percent, and it swung to a loss compared to a profit for the year-ago period.

The Austin, Texas-based molecular diagnostics instrumentation and assay maker had revenues of $29.1million for the three-month period ended Sept.30, compared to revenues of $28.9 million for the third quarter last year. Sales for its technology group fell to $22 million from $22.6 million, while sales for its assay group rose to $7.1 million from $6.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.